title: Evaluation and management of glaucoma after keratoprosthesis.
abstract: OBJECTIVE
  To review the causes and treatment of glaucoma in Boston keratoprosthesis (K-pro) recipients.
  
  
  RESULTS
  Glaucoma exists in up to three-quarters of patients who undergo K-pro surgery. After K-pro placement, intraocular pressure (IOP) is measured by digital palpation, which has been found to be reliable in trained observers. The onset or progression of glaucoma in K-pro patients should be monitored through visual field testing, direct visualization and structural imaging of the optic nerve. Although medical therapy is an option, one-half to three-quarters of K-pro recipients are surgically managed with a glaucoma drainage device (GDD) or, less commonly, cyclophotocoagulation.
  
  
  CONCLUSIONS
  Glaucoma is a common and permanent blinding sequelae of K-pro surgery. In K-pro patients, elevated IOP and changes in the optic nerve head should result in a high index of suspicion for glaucoma. Management is frequently surgical and typically entails placement of a GDD.
authors.affiliation: University of Miami Miller School of Medicine, 900 NW 17th Street, Miami, FL 33136, USA. mbanitt@med.miami.edu
authors.forename: Michael
authors.initials: M
authors.lastname: Banitt
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D003316:Corneal Diseases / Q000601:surgery*; D018463:Filtering Surgery; D005901:Glaucoma / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D006801:Humans; D007429:Intraocular Pressure; D010173:Palpation; D011183:Postoperative Complications; D019736:Prostheses and Implants; D019919:Prosthesis Implantation; D041623:Tomography, Optical Coherence
chemical_list: D000959:Antihypertensive Agents